A Study to Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy
PHASE2
Hidradenitis suppurativa (HS) is a chronic and often painful inflammatory s...
A Study to Evaluate the Effectiveness and Safety of Treatments, Either Alone or in Combination, for the Treatment of Moderate to Severe Atopic Dermatitis
PHASE2
Atopic dermatitis (AD) is a skin condition that may cause a rash and itchin...
Status
Active Not Recruiting
Location
Peak Dermatology Aesthetics and Wellness Fountain Hills /ID# 272550
A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis
PHASE2
Ulcerative colitis (UC) is a type of inflammatory bowel disease that causes...
A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab
PHASE2
Hidradenitis suppurativa (HS) and atopic dermatitis (AD) are chronic inflam...
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABT-981 in Patients With Osteoarthritis of the Knee
PHASE1
To assess the safety, tolerability and pharmacokinetics of ABT-981 in patie...